{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:27:25Z","timestamp":1791224845740,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T00:00:00Z","timestamp":1123804800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1007\/s00345-005-0506-4","type":"journal-article","created":{"date-parts":[[2005,8,11]],"date-time":"2005-08-11T12:31:17Z","timestamp":1123763477000},"page":"236-242","source":"Crossref","is-referenced-by-count":11,"title":["Current usefulness of free\/total PSA ratio in the diagnosis of prostate cancer at an early stage"],"prefix":"10.1007","volume":"23","author":[{"given":"Christian","family":"Pfister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Basuyau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,8,12]]},"reference":[{"key":"506_CR1","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/clinchem\/44.6.1216","volume":"44","author":"Allard","year":"1998","unstructured":"Allard WJ, Zhan Z, Yeung KK (1998) Novel immunoassay for the measurement of complexed prostate-specific antigen in serum. Clin Chem 44:1216\u20131223","journal-title":"Clin Chem"},{"key":"506_CR2","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJM200105033441806","volume":"344","author":"Barry","year":"2001","unstructured":"Barry MJ (2001) Prostate specific antigen testing for early diagnosis of prostate cancer. N Engl J Med 344:1373\u20131377","journal-title":"N Engl J Med"},{"key":"506_CR3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0022-5347(17)37394-9","volume":"147","author":"Benson","year":"1992","unstructured":"Benson MC, Whang IS, Olsson CA, Mac Mahon DJ, Cooner WH (1992) The use of prostate-specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 147:817\u2013821","journal-title":"J Urol"},{"key":"506_CR4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0090-4295(98)00241-6","volume":"52","author":"Brawer","year":"1998","unstructured":"Brawer MK, Meyer GE, Letran JL, Bankson DD, Morris DL, Yeung KK et al. (1998) Measurement of complexed PSA improves specificity for early detection of prostate cancer. Urology 52:372\u2013378","journal-title":"Urology"},{"key":"506_CR5","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.1992.03480160073037","volume":"267","author":"Carter","year":"1992","unstructured":"Carter H, Pearson JD, Metter J, Brant LJ, Chan DW, Andres R, Fozard JL, Walsh PC (1992) Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267:2215","journal-title":"JAMA"},{"key":"506_CR6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/jama.1995.03530150038031","volume":"274","author":"Catalona","year":"1995","unstructured":"Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, Nader RB (1995) Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274:1214\u20131220","journal-title":"JAMA"},{"key":"506_CR7","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0022-5347(01)68187-4","volume":"158","author":"Catalona","year":"1997","unstructured":"Catalona WJ, Beiser JA, Smith DS (1997) Serum free prostate-specific antigen and prostate-specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies. J Urol 158:2162\u20132167","journal-title":"J Urol"},{"key":"506_CR8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000067994","volume":"36","author":"Chautard","year":"1999","unstructured":"Chautard D, Daver A, Mermod B, Tichet A, Bocquillon V, Soret J (1999) Values for the free to total prostatic-specific antigen ratio as a function of age: necessity of reference range validation. Eur Urol 36:181\u2013186","journal-title":"Eur Urol"},{"key":"506_CR9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0090-4295(99)80487-7","volume":"47","author":"Chen","year":"1996","unstructured":"Chen Y, Luderer A, Thiel R, Carlson G, Cuny C, Soriano T (1996) Using proportions of free to total prostate specific antigen, age, and total prostate specific antigen to predict the probability of prostate cancer. Urology 47:518\u2013524","journal-title":"Urology"},{"key":"506_CR10","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0022-5347(05)67711-7","volume":"163","author":"Djavan","year":"2000","unstructured":"Djavan B, Zlotta AR, Remzi, Ghawidel K, Basharkhah A, Schulman CC (2000) Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1051 men. J Urol 163:1144\u20131149","journal-title":"J Urol"},{"key":"506_CR11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0090-4295(02)01896-4","volume":"60","author":"Djavan","year":"2002","unstructured":"Djavan B, Remzi M, Zlotta AR, Ravery V, Hammerer P, Reissigl A et al. (2002) Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed\/total prostate-specific antigen ratio, free to total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial. Urology 60:4\u20139","journal-title":"Urology"},{"key":"506_CR12","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0022-5347(01)68192-8","volume":"158","author":"Haese","year":"1997","unstructured":"Haese A, Graefen M, Noldus J, Hammerer P, Huland E, Huland H (1997) Prostatic volume and ratio of free to total PSA in patients with prostatic cancer or benign prostatic hyperplasia. J Urol 158:2188\u20132192","journal-title":"J Urol"},{"key":"506_CR13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/clinchem\/46.1.55","volume":"46","author":"Jung","year":"2000","unstructured":"Jung K, Elgeti U, Lein M, Brux B, Sinha P, Rudolph B, Hauptmann S, Schnorr D, Loening S (2000) Ratio of free or complexed PSA to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer? Clin Chem 46:55\u201362","journal-title":"Clin Chem"},{"key":"506_CR14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0090-4295(94)90170-8","volume":"43","author":"Kalish","year":"1994","unstructured":"Kalish J, Cooner WH, Graham SD (1994) Serum PSA adjusted for volume transition zone is more accurate than PSA adjusted for total gland volume in detecting adenocarcinoma of the prostate. Urology 43:601\u2013606","journal-title":"Urology"},{"key":"506_CR15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1464-410x.1998.00566.x","volume":"81","author":"Masters","year":"1998","unstructured":"Masters JG, Keegan PE, Hildreth AJ, Greene DR (1998) Free\/total prostatic-specific antigen ratio: how helpful is it in detecting prostate cancer? Br J Urol 81:419\u2013423","journal-title":"Br J Urol"},{"key":"506_CR16","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/1097-0142(19940901)74:5<1615::AID-CNCR2820740520>3.0.CO;2-6","volume":"74","author":"Mettlin","year":"1994","unstructured":"Mettlin C, Littrup PJ, Kane RA, Murphy GP, Lee F, Chesley A, Badalament R, Mostofi FK (1994) Relative sensitivity and specificity of serum prostate specific antigen level compared with age-referenced, PSA density and PSA change. Cancer 74:1615\u20131620","journal-title":"Cancer"},{"key":"506_CR17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/0272989X9801800118","volume":"18","author":"Metz","year":"1998","unstructured":"Metz CE, Herman BA, Roe CA (1998) Statistical comparison of two ROC-curve estimates obtained from partially-paired datasets. Med Decis Making 18:110\u2013121","journal-title":"Med Decis Making"},{"key":"506_CR18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1464-410x.2000.00838.x","volume":"86","author":"Moon","year":"2000","unstructured":"Moon DG, Yu JW, Lee JG, Kim JJ, Koh SK, Cheon J (2000) The influence of prostate volume on the prostate-specific antigen level adjusted for the transition zone volume and free to total PSA ratio: a prospective study. BJU Int 86:670\u2013674","journal-title":"BJU Int"},{"key":"506_CR19","first-page":"887","volume":"6","author":"Morote","year":"1999","unstructured":"Morote J, Encabo G, Lopez M, De Torres IM (1999) Individual variations of total and percent free serum prostatic specific antigen: could the change the indication of prostate biopsy? Oncol Rep 6:887\u2013890","journal-title":"Oncol Rep"},{"key":"506_CR20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000067981","volume":"36","author":"Morote","year":"1999","unstructured":"Morote J, Raventos CX, Lorente JA, Encabo G, Lopez M, De Torres IM (1999) Intra individual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination. Eur Urol 36:111\u2013115","journal-title":"Eur Urol"},{"key":"506_CR21","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1046\/j.1464-410x.2000.00526.x","volume":"85","author":"Patel","year":"2000","unstructured":"Patel D, White PAE, Milford W (2000) A comparison of six commercial assays for total and free PSA: the predictive value of the ratio of free to total PSA, prostate volume and age. Br J Urol 85:686\u2013689","journal-title":"Br J Urol"},{"key":"506_CR22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0022-5347(05)68543-6","volume":"162","author":"Polascik","year":"1999","unstructured":"Polascik TJ, Oesterling JE, Partin AW (1999) Prostate specific antigen a decade of discovery: what we have learned and where are we going? J Urol 162:293\u2013306","journal-title":"J Urol"},{"key":"506_CR23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0090-4295(02)02099-X","volume":"61","author":"Remzi","year":"2003","unstructured":"Remzi M, Djavan B, Wammack R, Momeni M, Seitz C, Erne B, Dobrovits M, Alavi S, Marberger M (2003) Can total and transition zone volume of the prostate determine whether to perform a repeat biopsy? Urology 61:161\u2013166","journal-title":"Urology"},{"key":"506_CR24","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1046\/j.1464-410x.2000.00858.x","volume":"86","author":"Semjonow","year":"2000","unstructured":"Semjonow A, De Angelis G, Oberpenning F, Schmid HP, Brand B, Hertle L (2000) The impact of different assays for prostate-specific antigen. BJU Int 86:590\u2013597","journal-title":"BJU Int"},{"key":"506_CR25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM198710083171501","volume":"317","author":"Stamey","year":"1987","unstructured":"Stamey TA, Yang N, Hay AR, Mac Neal JE, Freiha FS, Redwine E (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317:909\u2013916","journal-title":"N Engl J Med"},{"key":"506_CR26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<104::AID-CNCR15>3.0.CO;2-8","volume":"79","author":"Stephan","year":"1997","unstructured":"Stephan C, Lein M, Jung K, Schnorr D, Loening SA (1997) The influence of prostate volume on the ratio of free to total prostate-specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia. Cancer 79:104\u2013109","journal-title":"Cancer"},{"key":"506_CR27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1570-9124(03)00003-5","volume":"1","author":"Schmid","year":"2003","unstructured":"Schmid HP, Prikler L, Sturgeon CM, Semjonow A (2003) Diagnosis of prostate cancer. the use of prostate specific antigen. Eur Urol EAU Update Series 1:3\u20138","journal-title":"Eur Urol EAU Update Series"},{"key":"506_CR28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1464-410X.1998.00762.x","volume":"82","author":"De","year":"1998","unstructured":"De la Taille A, Houlgatte A, Houdelette P, Goluboff ET, Berlizot P, Ricordel I (1998) Influence of free to total prostate-specific antigen variability on the early diagnosis of prostate cancer: a comparative study of three immunoassays. Br J Urol 82:389\u2013389","journal-title":"Br J Urol"},{"key":"506_CR29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0090-4295(00)00450-7","volume":"55","author":"Terris","year":"2000","unstructured":"Terris M (2000) Extended field prostate biopsies: too much of a good thing? Urology 55:457\u2013460","journal-title":"Urology"},{"key":"506_CR30","first-page":"618","volume":"10","author":"Villers","year":"2000","unstructured":"Villers A, Chautard D (2000) Free PSA: its routine use is premature in screening of prostatic cancer. Prog Urol 10:618\u201321","journal-title":"Prog Urol"},{"key":"506_CR31","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0022-5347(01)64961-9","volume":"157","author":"Zlotta","year":"1997","unstructured":"Zlotta AR, Djavan B, Marberger M, Schulman CC (1997) Prostate-specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction. J Urol 157:1315\u20131321","journal-title":"J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-005-0506-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-005-0506-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-005-0506-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T21:31:11Z","timestamp":1586381471000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-005-0506-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,12]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["506"],"URL":"https:\/\/doi.org\/10.1007\/s00345-005-0506-4","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,12]]}}}